Skip to main content

Table 1 Demographic and clinical characteristics of the study cohort by diagnosis

From: Tuberous sclerosis complex is a novel, amyloid-independent tauopathy associated with elevated phosphorylated 3R/4R tau aggregation

 

Control (N = 11)

DS/AD (N = 9)a

TSC (N = 10)

FTD (N = 5)b

Age (Mean, SD)

52 (9)

53 (6)

49 (6)

69 (4)

Race (N, percent)

 Black

1 (9%)

1 (11%)

0 (0%)

0 (0%)

 White

8 (73%)

8 (89%)

10 (100%)

4 (80%)

 Unable to determine

2 (18%)

0 (0%)

0 (0%)

1 (20%)

 Sex (percent female)

46%

56%

50%

80%

Epilepsy diagnosis (N, Percent)

 Epilepsy present

0 (0%)

2 (22%)

5 (50%)

0 (0%)

 Epilepsy absent

11 (100%)

6 (67%)

3 (30%)

5 (100%)

 Unable to Determine

0 (0%)

1 (11%)

2 (20%)

0 (0%)

 IDD diagnosis (N, Percent)

0 (0%)

   

 IDD Present

0 (0%)

0 (0%)

5 (55%)

0 (0%)

 IDD Absent

11 (100%)

8 (89%)

3 (33%)

5 (100%)

 Unable to determine

0 (0%)

1 (11%)

2 (22%)

0 (0%)

  1. IDD Intellectual or developmental disability
  2. aThree subjects carried a clinical diagnosis of Down Syndrome
  3. bFour subjects had progressive supranuclear palsy (PSP), one had FTLD-tau, unclassified